ArticleOrphanet journal of rare diseases2011

Does market exclusivity hinder the development of Follow-on Orphan Medicinal Products in Europe?

Anne E M Brabers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.